Recombinant subunit vaccines against primate lentiviruses.
Hu
S L
SL
Bristol-Myers Squibb Pharmaceutical Research Institute, Seattle, Washington 98121, USA.
D000818:Animals; D015686:Gene Products, env / Q000276:immunology; D015683:Gene Products, gag / Q000276:immunology; D015684:Gene Products, pol / Q000276:immunology; D006801:Humans; D011995:Recombination, Genetic; D018449:SAIDS Vaccines / Q000276:immunology*; D016097:Simian Acquired Immunodeficiency Syndrome / Q000517:prevention & control*; D015302:Simian Immunodeficiency Virus / Q000276:immunology*
D015686:Gene Products, env; D015683:Gene Products, gag; D015684:Gene Products, pol; D018449:SAIDS Vaccines; C087575:SIV envelope glycoprotein gp160; C078684:simian immunodeficiency virus gp130